Nantahala Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-197,615
| Closed | -$865K | – | 116 |
|
|
2020
Q3 | $865K | Sell |
197,615
-75,723
| -28% | -$331K | 0.03% | 90 |
|
|
2020
Q2 | $2.52M | Hold |
273,338
| – | – | 0.08% | 81 |
|
|
2020
Q1 | $3.97M | Buy |
273,338
+22,892
| +9% | +$332K | 0.15% | 62 |
|
|
2019
Q4 | $2.96M | Buy |
250,446
+30,442
| +14% | +$360K | 0.09% | 63 |
|
|
2019
Q3 | $5.54M | Buy |
220,004
+92,609
| +73% | +$2.33M | 0.21% | 52 |
|
|
2019
Q2 | $3.24M | Buy |
+127,395
| New | +$3.24M | 0.1% | 68 |
|